Other: no doxycycline (DrugBank: Doxycycline)
15 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
23 | Prion disease | 0 |
28 | Systemic amyloidosis | 0 |
46 | Malignant rheumatoid arthritis | 0 |
84 | Sarcoidosis | 0 |
85 | Idiopathic interstitial pneumonia | 0 |
89 | Lymphangioleiomyomatosis | 0 |
96 | Crohn disease | 0 |
97 | Ulcerative colitis | 0 |
158 | Tuberous sclerosis | 0 |
162 | Pemphigoid | 0 |
167 | Marfan syndrome | 0 |
227 | Osler disease | 0 |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 0 |
299 | Cystic fibrosis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01323101 (ClinicalTrials.gov) | April 2008 | 15/2/2011 | Doxycycline Effects on Inflammation in Cystic Fibrosis | Effect of Doxycycline on Sputum Biomarkers of Inflammation and Lung Epithelial Repair in Patients With Cystic Fibrosis. | Cystic Fibrosis | Drug: Doxycycline;Other: No doxycycline | University of Southern California | NULL | Completed | 18 Years | N/A | All | 21 | Phase 4 | United States |